Categories
-
Adhesives
5
Amines
93
Amino Acids
180
Analytical Reagents
667
Antibiotics
251
Bioactive Small Molecules
719
Aroma Chemicals
204
Biochemicals
1008
Boronic Acids
4
Buffers
97
Building Blocks
1777
Carbohydrates
176
Catalysts
98
Chiral Compounds
54
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
250
Flavours and Fragrance Materials
202
Fluorinated Products
42
Furans
5
Gases in Solution
49
Grignard Reagents
19
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
324
Ion-Pair Reagents
24
Ligands
79
Organics
1300
Oxazoles
3
Peptide Reagents
90
Phenols
44
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
44
Reagents
97
Research Organics & Inorganics
752
Salts
282
Sealing Compounds
1
Sherclin
2
Solvents
121
Stains & Indicators
289
Sugars
63
Tailor-made solutions
3
Testing Standards
4
Uncategorised
161
Water Analysis
10
Arecoline hydrobromide
(11161105 | 300-08-3)
| CAS: | 300-08-3 |
|---|---|
| Molecular Formula: | C8H13NO2.HBr |
| Molecular Weight: | 236.11 |
| Availablility: | In Stock |
|---|---|
| Downloads: | | |
| 11161105-25g | 25g | £120.90 | |
| Bulk Order | |||
| 11161105-25g | 25g | €169.30 | |
| Bulk Order | |||
| 11161105-25g | 25g | $181.40 | |
| Bulk Order | |||
Safety Data Sheet
Certificate of Analysis
Product Detail
| Product Code | 11161105 | ||||
| Product Name | Arecoline hydrobromide | ||||
| Categories | Antibiotics Bioactive Small Molecules Biochemicals Research Organics & Inorganics | ||||
| CAS | 300-08-3 | ||||
| Molecular Formula | C8H13NO2.HBr | ||||
| Molecular Weight | 236.11 | ||||
| Storage Details | Ambient | ||||
| Harmonised Tariff Code | 2939799090 |
Product Specification
| Melting Point | 171 - 173℃ | ||||
| Heavy metals | ≤10ppm | ||||
| Identification | GC-MS | ||||
| Loss on Drying | ≤0.5% | ||||
| Solution | Clear and Transparent | ||||
| Appearance | White crystalline powder | ||||
| Assay (dry basis) | 98.0 - 100.0% |
Safety Information
| Pictograms |
|
||||
| Signal word | warning | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|